山东百龙创园生物科技股份有限公司2024年度股东大会决议公告

Group 1 - The core point of the article is the announcement of the resolutions from the 2024 Annual General Meeting of Shandong Bailong Chuangyuan Biotechnology Co., Ltd, which took place on May 20, 2025, with no resolutions being rejected [2][10] - The meeting was held at the company's office in Yucheng, Shandong Province, and was presided over by the chairman, Mr. Dou Baode, using a combination of on-site and online voting methods [2][3] - All current directors and supervisors attended the meeting, with a total of 9 directors and 5 supervisors present [3] Group 2 - The meeting approved several key proposals, including the 2024 Board of Directors' work report, the 2024 Supervisory Board's work report, and the financial budget for 2025 [4][5] - A special resolution regarding the profit distribution and capital reserve fund conversion into share capital for 2024 was passed, requiring more than two-thirds of the voting rights held by shareholders present [6][7] - The company plans to hold an investor briefing on June 6, 2025, to discuss the 2024 annual results and the first quarter of 2025, allowing investors to submit questions in advance [12][13]